Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 29,084	$ 22,787
Accounts receivable, net	5,810	3,273
Related party receivables, net	506	1,031
Prepaid expenses and other current assets	4,010	3,504
Total current assets	39,410	30,595
Property, plant and equipment, net	12,366	13,102
Goodwill	98,333	98,333
Intangible assets, net	39,039	47,969
Related party receivable, net of current	1,012	823
Operating lease right-of-use assets	6,048	7,539
Other assets	1,620	1,927
Total assets	197,828	200,288
Current liabilities
Accounts payable	3,204	5,122
Accrued and other current liabilities	16,358	13,975
Deferred revenue	2,440	1,166
Related party payables, net	5,161	4,238
Notes payable	782	268
Related party convertible note, net	0	9,411
Convertible notes, net	0	90,578
Total current liabilities	27,945	124,758
Deferred revenue, net of current	2,024	393
Related party liabilities	38,278	31,091
Related party promissory note	112,666	112,666
Related party convertible note, net	62,268	0
Convertible notes, net	74,603	0
Deferred income taxes, net	1,775	1,853
Operating lease liabilities	6,248	8,170
Other liabilities	34,013	32,757
Total liabilities	359,820	311,688
Commitments and Contingencies (Note 14)
Stockholders' deficit
Common stock, $0.0001 par value per share, 750,000,000 shares authorized; 115,505,244 and 111,284,733 shares issued and outstanding at December 31, 2021 and 2020, respectively	12	11
Additional paid-in capital	891,105	891,583
Accumulated deficit	(1,052,897)	(1,003,210)
Accumulated other comprehensive loss	(212)	(168)
Total NantHealth stockholders' deficit	(161,992)	(111,784)
Noncontrolling interests	0	384
Total stockholders' deficit	(161,992)	(111,400)
Total liabilities and stockholders' deficit	$ 197,828	$ 200,288